StocksFin Logo
Neogen Corporation country of incorporation
|
|
Mr. John Adent
|
2,108 employees
NASDAQ | Healthcare | Diagnostics & Research
Pacira BioSciences, Inc. country of incorporation
|
|
Mr. David Stack
|
697 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
Q123 reported Sep 30, 2022 Reporting Period
$132.35M 3.2% vs. Q122 Revenues Q123
47.05% 0.6% vs. Q122 Gross Profit Margin
3.94% -70.4% vs. Q122 Net Profit Margin
-27.14M ! -216.9% vs. Q122 Free Cash Flow Q123
$0.05 -68.5% vs. Q122 EPS Q123
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
Q322
Q322 reported Nov 3, 2022 Reporting Period
$167.47M 31.1% vs. Q321 Revenues Q322
69.74% -4.3% vs. Q321 Gross Profit Margin
-0.41% ! -103% vs. Q321 Net Profit Margin
37.47M -37.8% vs. Q321 Free Cash Flow Q322
$-0.02 ! -105% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Nov 30, 2022
Sep 30, 2022
Quick Ratio
2.75
3.21
Current Ratio
4.22
4.06
Cash Ratio
0.66
0.83
Price to Book
1.15
3.17
Price to Sales
15.56
14.56
Price to Earnings
-21.39
-879.42